144 related articles for article (PubMed ID: 31139222)
1. Assessment of the anatomical position of point B and the relationship between point B dose and the dose delivered to pelvic lymph nodes in CT-based high-dose-rate brachytherapy for uterine cervical cancer.
Matsukawa H; Sasaki T; Hirayama R; Hirose TA; Fukunaga JI
J Contemp Brachytherapy; 2019 Apr; 11(2):137-145. PubMed ID: 31139222
[TBL] [Abstract][Full Text] [Related]
2. Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy.
Lee LJ; Sadow CA; Russell A; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):803-9. PubMed ID: 19286328
[TBL] [Abstract][Full Text] [Related]
3. Dose to pelvic lymph nodes in image based high dose rate brachytherapy of carcinoma cervix.
Rangarajan R; Subramanian S; Gopalakrishnan K; Jothi V; Krishnamurthy K
Rep Pract Oncol Radiother; 2019; 24(1):80-85. PubMed ID: 30505237
[TBL] [Abstract][Full Text] [Related]
4. Delineating the relationship between Point A prescription dose and pelvic lymph node doses in intracavitary high-dose-rate brachytherapy treatment of cervical cancer for use in low- and middle-income countries.
Weaver J; Harmon G; Harkenrider MM; Surucu M; Wood A; Alite F; Small W
Brachytherapy; 2018; 17(1):201-207. PubMed ID: 29066085
[TBL] [Abstract][Full Text] [Related]
5. Dose to pelvic lymph nodes in locally advanced cervical cancer during high-dose-rate brachytherapy with tandem-ring applicators.
Moghani MM; Siavashpour Z; Ogorodniitchouk O; Moreno-Acosta P; Plattard D; Vallard A; Sotton S; Bouleftour W; Langrand-Escure J; Magné N
J Contemp Brachytherapy; 2022 Apr; 14(2):183-188. PubMed ID: 35494178
[TBL] [Abstract][Full Text] [Related]
6. Dose to pelvic lymph nodes during brachytherapy of locally advanced cervical cancer with 60Co HDR source.
Siavashpour Z; Aghili M; Anjidani S; Zayeri F; Moghani MM; Maleki M; Jaberi R
Brachytherapy; 2022; 21(2):158-169. PubMed ID: 34750084
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of doses to pelvic lymph node regions from image-guided high-dose-rate interstitial brachytherapy for carcinoma of the uterine cervix.
Gandhi AK; Rastogi M; Mishra VK; Srivastava AK; Khatoon F; Sharma DN
J Contemp Brachytherapy; 2023 Aug; 15(4):261-268. PubMed ID: 37799125
[TBL] [Abstract][Full Text] [Related]
8. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
[TBL] [Abstract][Full Text] [Related]
9. Contribution of image-guided adaptive brachytherapy to pelvic nodes treatment in locally advanced cervical cancer.
Bacorro W; Dumas I; Levy A; Rivin Del Campo E; Canova CH; Felefly T; Huertas A; Marsolat F; Haie-Meder C; Chargari C; Mazeron R
Brachytherapy; 2017; 16(2):366-372. PubMed ID: 28159552
[TBL] [Abstract][Full Text] [Related]
10. Assessing dose contribution to pelvic lymph nodes in intracavitary brachytherapy for cervical cancer.
Chua GWY; Foo YW; Tay GH; Tan DBH
J Contemp Brachytherapy; 2017 Aug; 9(4):345-353. PubMed ID: 28951754
[TBL] [Abstract][Full Text] [Related]
11. Late rectal toxicity determined by dose-volume parameters in computed tomography-based brachytherapy for locally advanced cervical cancer.
Zhou YC; Zhao LN; Wang N; Hu J; Sun XH; Zhang Y; Li JP; Li WW; Liu JY; Wei LC; Shi M
Cancer Med; 2016 Mar; 5(3):434-41. PubMed ID: 26806114
[TBL] [Abstract][Full Text] [Related]
12. Equivalent dose in 2 Gy (EQD2) to pelvic lymph nodes using volume based prescription for three brachytherapy applicators - a dosimetric retrospective analysis.
Revathy T; Vidyasagar N; Gururajachar JM; Thiruraj AP; Koushik AK; Alva RC; Kumar SM
Rep Pract Oncol Radiother; 2021; 26(3):408-415. PubMed ID: 34277094
[TBL] [Abstract][Full Text] [Related]
13. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.
Kim Y; Kim YJ; Kim JY; Lim YK; Jeong C; Jeong J; Kim M; Lim MC; Seo SS; Park SY
Brachytherapy; 2017; 16(1):116-125. PubMed ID: 27876378
[TBL] [Abstract][Full Text] [Related]
14. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
[TBL] [Abstract][Full Text] [Related]
15. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
[TBL] [Abstract][Full Text] [Related]
16. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.
Lee YC; Rash DL; Stern RL; Mayadev JS
Brachytherapy; 2013; 12(6):555-9. PubMed ID: 23880417
[TBL] [Abstract][Full Text] [Related]
17. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
[TBL] [Abstract][Full Text] [Related]
18. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
20. Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose-volume histogram parameter reproducibility and anatomic position stability.
Flower E; Do V; Sykes J; Dempsey C; Holloway L; Summerhayes K; Thwaites DI
Brachytherapy; 2017; 16(2):387-392. PubMed ID: 28161434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
